IN2012DN00696A - - Google Patents

Download PDF

Info

Publication number: IN2012DN00696A
Authority: IN; India
Prior art keywords: iodophenylamino; dihydroxypropyl; cyclopropane; sulfonamide; difluoro
Prior art date: 2009-07-24

Application number

Other languages

English (en)

Inventor

Maderna Andreas

Vernier Jean-Michel

Original Assignee

Ardea Biosciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-07-24

Filing date

2010-07-10

Publication date

2015-06-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42830488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN00696(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-07-10 Application filed by Ardea Biosciences Inc filed Critical Ardea Biosciences Inc

2015-06-19 Publication of IN2012DN00696A publication Critical patent/IN2012DN00696A/en

Links

RDSACQWTXKSHJT-LLVKDONJSA-N n-[3,4-difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2r)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide Chemical compound C1CC1(C[C@@H](O)CO)S(=O)(=O)NC=1C(OC)=CC(F)=C(F)C=1NC1=CC=C(I)C=C1F RDSACQWTXKSHJT-LLVKDONJSA-N 0.000 abstract 1
RDSACQWTXKSHJT-NSHDSACASA-N n-[3,4-difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2s)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide Chemical compound C1CC1(C[C@H](O)CO)S(=O)(=O)NC=1C(OC)=CC(F)=C(F)C=1NC1=CC=C(I)C=C1F RDSACQWTXKSHJT-NSHDSACASA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
- C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
- C07C29/80—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by distillation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

IN696DEN2012 2009-07-24 2010-07-10 IN2012DN00696A (he)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US22850109P	2009-07-24	2009-07-24
US22850909P	2009-07-24	2009-07-24
PCT/EP2010/004222 WO2011009541A1 (en)	2009-07-24	2010-07-10	Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof

Publications (1)

Publication Number	Publication Date
IN2012DN00696A true IN2012DN00696A (he)	2015-06-19

Family

ID=42830488

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN696DEN2012 IN2012DN00696A (he)	2009-07-24	2010-07-10

Country Status (31)

Country	Link
US (3)	US8513443B2 (he)
EP (1)	EP2462111B1 (he)
JP (1)	JP5776115B2 (he)
KR (1)	KR101763437B1 (he)
CN (2)	CN102471246B (he)
AR (1)	AR079183A1 (he)
AU (1)	AU2010275780B2 (he)
BR (1)	BR112012001592A2 (he)
CA (2)	CA2990097A1 (he)
CL (1)	CL2012000192A1 (he)
CO (1)	CO6491075A2 (he)
CR (1)	CR20120044A (he)
CU (1)	CU24113B1 (he)
DO (1)	DOP2012000017A (he)
EA (1)	EA023623B1 (he)
EC (1)	ECSP12011621A (he)
GT (1)	GT201200017A (he)
HN (1)	HN2012000142A (he)
IL (1)	IL217312A (he)
IN (1)	IN2012DN00696A (he)
MA (1)	MA33452B1 (he)
MX (2)	MX2012001063A (he)
MY (1)	MY160421A (he)
NZ (1)	NZ597738A (he)
PE (1)	PE20120573A1 (he)
PH (1)	PH12014500158B1 (he)
SG (1)	SG177535A1 (he)
TN (1)	TN2012000027A1 (he)
TW (1)	TWI524890B (he)
UY (1)	UY32800A (he)
WO (1)	WO2011009541A1 (he)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI524890B (zh)	2009-07-24	2016-03-11	亞德生化公司	（ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備
AU2012264884B2 (en) *	2011-05-27	2017-03-09	Bayer Intellectual Property Gmbh	Chiral synthesis of N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[2,3-dihydroxy-propyl]cyclopropanesulfonamides
CN104011039A (zh) *	2011-12-19	2014-08-27	住友化学株式会社	磺酸盐的制造方法
EP2848246A1 (en)	2013-09-13	2015-03-18	Bayer Pharma Aktiengesellschaft	Pharmaceutical compositions containing refametinib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI1912636T1 (sl) *	2005-07-21	2014-08-29	Ardea Biosciences, Inc.	N-(arilamino)-sulfonamidni inhibitorji MEK
US8101799B2 (en) *	2005-07-21	2012-01-24	Ardea Biosciences	Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
US7842836B2 (en)	2006-04-11	2010-11-30	Ardea Biosciences	N-aryl-N'alkyl sulfamides as MEK inhibitors
JP5269762B2 (ja) *	2006-04-18	2013-08-21	アーディア・バイオサイエンシーズ・インコーポレイテッド	Ｍｅｋ阻害剤としてのピリドンスルホンアミドおよびピリドンスルファミド
CA2924436A1 (en) *	2007-07-30	2009-02-05	Ardea Biosciences, Inc.	Pharmaceutical combinations of n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide as inhibitors of mek and methods of use
MX2010011314A (es) *	2008-04-14	2010-11-12	Ardea Biosciences Inc	Composiciones y metodos de preparacion y uso de las mismas.
TWI524890B (zh) *	2009-07-24	2016-03-11	亞德生化公司	（ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備

2010
- 2010-07-09 TW TW099122740A patent/TWI524890B/zh not_active IP Right Cessation
- 2010-07-10 KR KR1020127001737A patent/KR101763437B1/ko not_active Expired - Fee Related
- 2010-07-10 EP EP10734043.2A patent/EP2462111B1/en active Active
- 2010-07-10 PE PE2012000092A patent/PE20120573A1/es not_active Application Discontinuation
- 2010-07-10 JP JP2012520927A patent/JP5776115B2/ja not_active Expired - Fee Related
- 2010-07-10 CA CA2990097A patent/CA2990097A1/en not_active Abandoned
- 2010-07-10 WO PCT/EP2010/004222 patent/WO2011009541A1/en not_active Ceased
- 2010-07-10 US US13/386,519 patent/US8513443B2/en not_active Expired - Fee Related
- 2010-07-10 AU AU2010275780A patent/AU2010275780B2/en not_active Ceased
- 2010-07-10 CA CA2768788A patent/CA2768788C/en not_active Expired - Fee Related
- 2010-07-10 IN IN696DEN2012 patent/IN2012DN00696A/en unknown
- 2010-07-10 EA EA201200175A patent/EA023623B1/ru not_active IP Right Cessation
- 2010-07-10 CN CN201080031572.6A patent/CN102471246B/zh not_active Expired - Fee Related
- 2010-07-10 BR BR112012001592A patent/BR112012001592A2/pt not_active Application Discontinuation
- 2010-07-10 MY MYPI2012000099A patent/MY160421A/en unknown
- 2010-07-10 SG SG2012000964A patent/SG177535A1/en unknown
- 2010-07-10 CN CN201310670649.XA patent/CN103848808B/zh not_active Expired - Fee Related
- 2010-07-10 MA MA34562A patent/MA33452B1/fr unknown
- 2010-07-10 NZ NZ597738A patent/NZ597738A/en not_active IP Right Cessation
- 2010-07-10 MX MX2012001063A patent/MX2012001063A/es active IP Right Grant
- 2010-07-10 CU CUP2012000014A patent/CU24113B1/es active IP Right Grant
- 2010-07-22 UY UY0001032800A patent/UY32800A/es not_active Application Discontinuation
- 2010-07-23 AR ARP100102678A patent/AR079183A1/es unknown
2012
- 2012-01-01 IL IL217312A patent/IL217312A/he not_active IP Right Cessation
- 2012-01-19 TN TNP2012000027A patent/TN2012000027A1/en unknown
- 2012-01-23 CR CR20120044A patent/CR20120044A/es unknown
- 2012-01-24 HN HN2012000142A patent/HN2012000142A/es unknown
- 2012-01-24 EC EC2012011621A patent/ECSP12011621A/es unknown
- 2012-01-24 CO CO12010431A patent/CO6491075A2/es active IP Right Grant
- 2012-01-24 GT GT201200017A patent/GT201200017A/es unknown
- 2012-01-24 MX MX2014000732A patent/MX344965B/es unknown
- 2012-01-24 CL CL2012000192A patent/CL2012000192A1/es unknown
- 2012-01-24 DO DO2012000017A patent/DOP2012000017A/es unknown
2013
- 2013-04-23 US US13/868,621 patent/US8884058B2/en not_active Expired - Fee Related
2014
- 2014-01-16 PH PH12014500158A patent/PH12014500158B1/en unknown
- 2014-08-25 US US14/467,424 patent/US9296686B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2768788A1 (en)	2011-01-27
ECSP12011621A (es)	2012-02-29
KR20120032536A (ko)	2012-04-05
CL2012000192A1 (es)	2012-10-05
CN102471246A (zh)	2012-05-23
AU2010275780A1 (en)	2012-02-02
US20130261320A1 (en)	2013-10-03
WO2011009541A1 (en)	2011-01-27
TWI524890B (zh)	2016-03-11
US20120178946A1 (en)	2012-07-12
MX344965B (es)	2017-01-12
TN2012000027A1 (en)	2013-09-19
EA201200175A1 (ru)	2012-12-28
TW201113017A (en)	2011-04-16
NZ597738A (en)	2014-03-28
DOP2012000017A (es)	2012-05-15
MX2012001063A (es)	2012-03-26
BR112012001592A2 (pt)	2016-03-08
JP2013500242A (ja)	2013-01-07
MA33452B1 (fr)	2012-07-03
CU24113B1 (es)	2015-08-27
KR101763437B1 (ko)	2017-07-31
EP2462111A1 (en)	2012-06-13
AU2010275780B2 (en)	2015-10-22
HK1171218A1 (en)	2013-03-22
PE20120573A1 (es)	2012-05-17
EP2462111B1 (en)	2016-03-30
CN103848808B (zh)	2016-02-10
CA2990097A1 (en)	2011-01-27
MY160421A (en)	2017-03-15
PH12014500158A1 (en)	2015-09-07
IL217312A (he)	2017-02-28
US8884058B2 (en)	2014-11-11
CN103848808A (zh)	2014-06-11
CR20120044A (es)	2012-03-12
HK1198364A1 (zh)	2015-04-10
SG177535A1 (en)	2012-03-29
US20150274651A1 (en)	2015-10-01
US9296686B2 (en)	2016-03-29
CN102471246B (zh)	2015-08-26
US8513443B2 (en)	2013-08-20
CO6491075A2 (es)	2012-07-31
AR079183A1 (es)	2012-01-04
JP5776115B2 (ja)	2015-09-09
GT201200017A (es)	2013-12-19
IL217312A0 (en)	2012-02-29
HN2012000142A (es)	2015-06-08
PH12014500158B1 (en)	2015-09-07
CA2768788C (en)	2018-01-09
EA023623B1 (ru)	2016-06-30
CU20120014A7 (es)	2012-06-21
UY32800A (es)	2011-01-31

Publication	Publication Date	Title
EP2371347A3 (en)	2015-09-16	Oral care compositions
PH12017502300A1 (en)	2018-06-25	Pesticidal compositions and processes related thereto
WO2011061330A3 (de)	2011-07-21	Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
MX2013009175A (es)	2013-08-29	Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.
WO2011106322A3 (en)	2012-02-02	Biomarkers for acute ischemic stroke
PH12012501346A1 (en)	2012-12-17	Heteroaryl compounds and uses thereof
IN2012DN06629A (he)	2015-10-23
PH12013500360B1 (en)	2018-12-12	Pesticidal compositions
MX2011014019A (es)	2012-02-22	Derivados de diazahomoadamantano y sus metodos de uso.
WO2010118291A3 (en)	2011-02-17	Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
IN2012DN00696A (he)	2015-06-19
MX2012011382A (es)	2013-01-29	Nuevo polimero.
UA106762C2 (uk)	2014-10-10	Спосіб одержання (r)- та (s)-n-(3,4-дифтор-2-(2-фтор-4-йодфеніламіно)-6-метоксифеніл)-1-(2,3-дигідроксипропіл)циклопропан-1-сульфанаміду та його захищених похідних
MY179784A (en)	2020-11-13	Use of cathepsin h
WO2012027274A3 (en)	2012-06-07	Compositions and methods for imaging
AU2017202012A1 (en)	2017-04-20	Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo(3.1.0)hexane in the treatment of conditions affected by monoamine neurotransmitters
UA106192C2 (en)	2014-08-11	N-(1,1-dioxotetrahydrothiophen-3-yl)bicyclo[2.2.1]hept-5-ene-endo,endo-2,3- dicarboximide and n-(1,1-dioxotetrahydrothiophen-3-yl)-exo-5,6-epoxybicyclo-[2.2.1]heptane-endo,endo-2,3-dicarboximide exhibiting analgetic and anticonvulsant action
UA91166C2 (en)	2010-06-25	use of ethyl ether N-[(2-oxoindolylinylydene-3)-2-oxyacetyl]-aminoacetic acid of the general formula as nootropic and anxyolytic agent
UA35660U (en)	2008-09-25	Use of antihomotoxic preparations as cytoprotectors
HK1182734A (en)	2013-12-06	Nanozymes, methods of making nanozymes, and methods of using nanozymes
UA59343U (ru)	2011-05-10	Применение теобона-дитиомикоцида (n -(1,1-диоксотиолан-3-ил)-дитиокарбамата калия) как средства для лечения инфекционных поражений кожи
UA52529U (ru)	2010-08-25	Применение уретроскопа комбинированного (модель 513) как троакарной системы для эпицистостомии
UA60476U (ru)	2011-06-25	Применение (1,1-диоксотиолан-3-ил)дитиокарбамата калия в качестве антимикробного средства
UA96059C2 (ru)	2011-09-26	Применение липина как средства фригопротекторного действия